Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Several firms sold off shares of Thermo Fisher Scientific, but the company reported strong earnings and raised its dividend.
Several financial firms have reduced their holdings in Thermo Fisher Scientific Inc., including Summit Financial LLC, Boston Family Office LLC, and Front Row Advisors LLC.
Despite these sales, Thermo Fisher Scientific reported strong earnings, beating analyst expectations.
The company's stock is rated as a "Moderate Buy" with a target price of $653.23.
Thermo Fisher Scientific provides various life sciences solutions and services globally and recently increased its quarterly dividend to $0.43 per share, up from $0.39, yielding 0.35%.
17 Articles
Varias empresas vendieron acciones de Thermo Fisher Scientific, pero la compañía reportó fuertes ganancias y aumentó su dividendo.